Top compounds associated with response to PSMD7


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 9e-06
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 4e-05
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA BRD1812 CTRPv2 pan-cancer AAC -0.13 0.0002
Download CSV